Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
Description | Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities. |
In vitro | UPLC-QTOF-MA-Markerlynx, principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis were used for data analysis and tracking changes of chemical composition during the decocting process. In vitro platelet aggregation induced by ADP, thrombin time(TT) and prothrombin time (PT) were investigated for Puhuang-Wulingzhi before and after compatibility. The results showed that significant differences were found between the mixed decoction and codecoction of Wulingzhi and Puhuang. Five compounds changed obviously were identified as typhaneoside, naringenin, isorhamnetin-3-O-ruinoside, Quercetin 3-O-neohesperidoside, kaempferol-3-O-neohesperidoside[1] |
Source |
Molecular Weight | 610.52 |
Formula | C27H30O16 |
CAS No. | 32453-36-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Quercetin 3-O-neohesperidoside 32453-36-4 Others Quercetin 3Oneohesperidoside Quercetin 3 O neohesperidoside inhibitor inhibit